Biopharmaceutical company engaged in research, development and marketing of new medicines.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2023 | COVINGTON & BURLING LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— |
| Firm | Filings | Expenses |
|---|---|---|
| COVINGTON & BURLING LLP | 18 | — |
| Issue | Activities |
|---|---|
| Health Issues | 17 |